Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached?

This publication has 15 references indexed in Scilit:

• Goserelin Acetate (Zoladex) with or without Hormone Replacement Therapy for the Treatment of Endometriosis
  Fertility and Sterility, 1998
• Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study
  Obstetrics & Gynecology, 1998
• The Role of GnRH Agonists Plus Add-Back Therapy in the Treatment of Endometriosis
  Seminars in Reproductive Medicine, 1997
• Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis
  Fertility and Sterility, 1997
• Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side effects of gonadotropin-releasing hormone agonist without changing its efficacy in endometriosis
  Fertility and Sterility, 1996
• Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis
  Fertility and Sterility, 1995
• Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial
  Journal of Clinical Endocrinology & Metabolism, 1992
• Hormone treatment of endometriosis: The estrogenthreshold hypothesis
  American Journal of Obstetrics and Gynecology, 1992
• Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists?
  Journal of Clinical Endocrinology & Metabolism, 1990
• Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis
  New England Journal of Medicine, 1988